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Summary
Vesicular stomatitis virus (VSV), the prototypic rhabdovirus, has been used as an excellent
paradigm for understanding the mechanisms of virus replication, pathogenesis, host
response to virus infection and also for myriads of studies on cellular and molecular
biology. Biochemical studies as well as high-throughput genomics, proteomics, and
chemical approaches have revealed a plethora of cellular factors and pathways that regulate
replication of VSV. These factors include those that support virus replication and also those
that restrict its replication. This chapter discusses the role(s) of many of these host cell
factors and pathways involved in VSV replication. Although mechanistic understanding
of the roles of some of these factors in VSV replication has been obtained, the roles of many
others need to be investigated for a better understanding of the virus-host cell interactions.
Introduction
Vesicular stomatitis virus (VSV) is an enveloped, non-segmented negative stranded (NNS)
RNA virus in the family Rhabdoviridae and order Mononegavirales. Members of the family
have been classified into eleven genera primarily based on antigenicity and phylogenetic
1
analyses. Among them, the vesiculoviruses (prototype: VSV) and the lyssaviruses
[prototype: rabies virus (RABV)] are the best characterized. Novel and emerging
rhabdoviruses are continuously being identified and characterized (see chapter 13), many
of which are yet to be classified due to lack of genome sequence information and low
number of identified representative viruses in serogroups.
The two known serotypes of VSV [Indiana (VSVI) and New Jersey (VSVNJ)] share
2
many similar properties although differences have been reported. VSVI is the most well
characterized serotype. Its negative- sense RNA genome encodes 5 major proteins: the
nucleocapsid protein (N), the phosphoprotein (P), the matrix (M), the glycoprotein (G) and
the large polymerase protein (L). Inside the virion, the viral genome is tightly encapsidated
with the N protein to form ribonucleocapsid complex (RNP or NC) with which the viral
RNA dependent RNA polymerase (RdRp) complex of P-L proteins is associated. The G
protein forms spikes on the surface of VSV virions and is responsible for attachment to host
cells. Both M and G proteins are required for assembly and budding of infectious particles.
Following entry by endocytosis, the G protein mediates fusion of the viral envelope with
the endosomal membrane, thereby releasing the viral RNP into the cytoplasm. The RNP
undergoes primary transcription by the associated RdRp to produce five capped and
1
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polyadenylated mRNAs, which are translated by the cellular translation machinery to
generate the viral proteins for further steps in the infection process including genome
3
replication, secondary transcription, virus assembly, and budding.
VSV has been used as a workhorse for studying virus replication mechanisms,
pathogenesis, evolution, and virus-host interactions as well as understanding many aspects
of cellular and molecular biology. With the development of the reverse genetics system in
4
the early 1990’s using a defective interfering (DI) particle of VSV, recovery of infectious
5-7
RABV and VSV soon followed. Manipulation of full-length viral genomes and recovery
of infectious viruses encoding a variety of foreign proteins have resulted in the use of these
“designer viruses” as vaccine vectors (see chapter 9), as cancer therapeutics (chapter 10),
and for myriads of studies on molecular and cellular biology of virus replication (chapters
3, 5, and 8) and pathogenic mechanisms (chapters 7 and 15).
Since VSV has been widely recognized as a valuable research tool with promising
applications, recent efforts have focused on understanding its interaction with host cells
by identification of crucial host factors using high throughput genomics, proteomics, and
chemical approaches. This chapter describes our current understanding of the role(s) of
the host functions in VSV replication, with a focus on recent findings on the cellular factors
and pathways that regulate various steps in the viral life cycle.
Host Functions Involved in Early Stages of VSV Infection
Attachment
Although VSV has been studied for over four decades, the key cellular factor(s) driving its
8
pantropism has not been unequivocally identified. The low density lipoproteins (LDLs)
9-11
10
and the phospholipids,
in particular, phosphatidylserine (PS) were described as
molecules responsible for VSV attachment to host cells. Subsequent studies revealed that
12
PS is unlikely to serve such a role, although it may be involved in a post-binding steps of
virus entry. Since the extent of G protein conformational change depends on the presence
of PS on the target membrane and the rate of fusion reaction was remarkably increased
13
when the PS content was increased, the function of PS in VSV infection process may
likely be to support a fusion step during the uncoating of viral RNPs. Other membrane
lipids, like sialoglycolipids (gangliosides) but not asialoglycolipids (cerebrosides) were also
14,15
implicated in the virus attachment to host cells.
However, a recent study has identified
the LDL receptor (LDLR) as the major receptor and other LDLR family members, as the
16
alternative receptors for VSV entry. LDLR family members are ubiquitously expressed
in all cells and tissues across the animal kingdom and their specific interaction with the G
16
protein may account for the pantropism of VSV.
In addition, VSV binding to the target membrane may further depend on electrostatic
interactions between positive charges on the G protein and negatively charged
13,17
phospholipids in the cellular membranes.
The observation that removal of negatively
charged polar head groups from these lipid molecules significantly reduces VSV attachment
18,19
and fusion while the presence of polycation DEAE-dextran enhances VSV entry
further
strengthens this contention. The observed requirement for the endoplasmic reticulum (ER)
chaperone gp96, a component of the multiprotein complex required for protein folding in
20
the ER, in VSV binding to cells is likely to be indirect, as it is involved in glycosylation of
16
LDLR.
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Entry and NC Release
The attached VSV virion is internalized by receptor-mediated endocytosis in clathrin coated
21-23
24
vesicles
in a dynamin-2-dependent manner. Since the average size of VSV (200nm
long) is significantly larger than the dimensions of typical clathrin-coated pits, the vesicles
used for clathrin-mediated endocytosis (CME) of VSV are not fully coated with clathrin
22
and require actin polymerization for efficient internalization. However, endocytosis of
smaller VSV particles, such as the defective interfering (DI-T) particles (75nm long) does
23
not necessitate actin assembly. VSV G protein is responsible for both virus attachment
25
and uncoating of viral RNP into the cytosol in a RAB5- dependent manner. RhoB and
RhoC members of the Rho GTPase family which regulate many cellular aspects such
26
as actin dynamics, cell proliferation, apoptosis, and gene expression also modulate
27
VSV entry. Phosphorylation by cellular kinases is necessary for VSV entry as has been
28
29
demonstrated by the use of kinase inhibitors and kinome siRNA screen. Okadaic acid, a
28
serine/threonine phosphatase inhibitor, inhibits viral penetration and uncoating. Elegant
studies to identify kinases involved in endocytic pathways revealed at least 48 kinases that
29
act at different stages of endocytic pathway to be required for VSV entry by CME. Among
them, kinases involved in cytoskeleton-dependent transport, G-protein receptor-linked
kinases and kinases that regulate the mammalian target of rapamycin (mTOR)-dependent
29
signaling and the Wnt/β-catenin signaling were identified. Mechanistic understanding
of the role(s) of these kinases and pathways in VSV entry warrants further investigation.
Following endocytic entry, VSV uncoating involves low pH dependent conformational
change in G protein to induce fusion of viral envelope with the membrane of internal
vesicles present in the multivesicular bodies (MVBs) inside the endosomes followed by a
back- fusion of these internal vesicles with the limiting membrane of the late endosomes to
30
release viral RNP into the cytoplasm (see chapter 3 for further details). Using fluorescent
VSVs, studies show that the release of the viral RNPs into the cytoplasm occurs within 2025,31
30 min after binding of the virus to the host cell plasma membrane.
The RNP release
depends on the lipid lysobisphosphatidic acid (LBPA), which is only found in the late
endosomes and its putative effector, ALG-2-interacting protein 1 (AIP1/ALIX), and are
30
regulated by phosphatidylinositol-3- phosphate. Recent studies show that interaction
32
of LBPA with ALIX is required for RNP release. LBPA was also recently shown to
preferentially influence the ability of VSV G to mediate lipid mixing during membrane
33,34
fusion.
Depletion of several subunits of the endosomal sorting complex required for
30,32
transport (ESCRT) pathway results in inhibition of VSV RNA synthesis during infection,
suggesting that components of the ESCRT machinery are also required for the release of
the viral RNPs into the cytoplasm from the endosomes.
Host Functions in Viral Macromolecular Synthesis
Viral mRNA Transcription
After release into the cytoplasm, the RNP template-associated viral RdRp complex
performs primary transcription to produce the viral mRNAs from the input template. The
mRNAs are translated to generate the viral proteins including N, P, and L proteins, which
then carry out replication of the input viral genome to generate multiple progeny genomes.
The newly synthesized negative-sense RNPs then undergo secondary transcription which
amplifies the amount of viral mRNAs and proteins for further rounds of replication.
Cyclophilin A (CypA), a chaperone protein possessing peptidyl cis-trans prolyl-isomerase
activity, is required for primary transcription of VSVNJ genome but not the VSVI genome.
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The enzymatic activity of CypA appears to be important, since its inhibition by cyclosporine
35
A results in inhibition of primary transcription of VSVNJ by 85-90%. Biochemical and
mutational studies have shown that the viral RdRp involved in transcription is distinct
from that involved in genome replication. Two distinct RdRp complexes have been isolated
from infected cells and characterized. One complex, comprising of the viral L and P proteins
along with the cellular guanylyltransferase, translation elongation factor 1α, and heat
shock protein 60, was found to exclusively synthesize mRNAs and is thus called the viral
transcriptase. The other complex, comprising of the viral L, P, and N proteins, synthesizes
36
only the full- length encapsidated replication products and is termed the viral replicase.
Although the exact role of the cellular proteins in viral transcriptase complex is not known,
they may facilitate viral transcription. Further studies are required to understand their role
in VSV transcription.
VSV mRNAs, like most eukaryotic mRNAs, are capped, methylated, and polyadenylated
and these modifications are carried out by the viral RdRp (see chapter 5 for further
details). Methylation of VSV mRNAs to form 5'-terminal structures is required for efficient
translation in infected cells. Capping of the nascent transcripts is also important for
37
transcription elongation and failure of correct 5’ capping results in abortive transcription.
VSV RdRp executes the capping reaction differently by adding GDP instead of GMP (as
38
seen in eukaryotic capping) to the viral mRNAs but not to the Le RNA. Whether this
unique mechanism of capping of the mRNAs by the viral RdRp is regulated by cellular
and/or viral factors is not known but is of interest for identifying specific targets for
therapeutic development.
Phosphorylation by cellular protein kinases plays important roles in VSV infection
not only during virus entry but also for viral gene expression. This was demonstrated
by the effects on viral growth when the overall levels of protein phosphorylation were
28,39
either enhanced or inhibited.
The VSV P protein is a multifunctional protein that is
phosphorylated by cellular kinase(s) for its function in viral genome transcription and
40-43
replication.
Although casein kinase II (CKII), a serine/threonine kinase, has been
44-46
identified as one of the kinases involved in phosphorylation of P protein,
other kinases
may also be involved as demonstrated by the use of inhibitors that do not affect CKII
39
but block VSV RNA synthesis significantly. With the recent identification of a tyrosine
47
phosphorylation site in the P protein, it is possible that other cellular kinase(s) may also
mediate P phosphorylation for transcription and replication.
Viral Protein Synthesis
VSV mRNAs are translated in a cap-dependent manner by the host cells translation
machinery. In the face of ongoing cellular mRNA translation, VSV usurps the translation
machinery to preferentially translate its mRNAs via multiple mechanisms. The cellular
eIF4F is a multisubunit complex involved in cap-dependent translation of host mRNAs.
eIF4F regulates host translation through phosphorylation of cap-binding protein eIF4E,
a subunit of the eIF4F complex. VSV infection leads to dephosphorylation of eIF4E and
the translation inhibitor 4E-BP1 (eIF4E- binding protein 1), resulting in lower levels of
eIF4F complex. Although the mechanism(s) by which VSV mediates these modifications
is unknown at this time, this strategy allows the virus to subvert the cellular translation
48
machinery for preferential translation of the viral mRNAs. In addition, it appears that the
cellular site of the transcription also contribute to the fate of the transcripts. Nascent viral
mRNAs made in the cytoplasm are preferentially translated while translation of the host
49,50
mRNAs is inhibited during VSV infection.
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VSV mRNA synthesis occurs throughout the host cell cytoplasm
in inclusion bodies
52
that contain the viral RNA synthesis machinery. The mRNAs are transported from the
52
inclusion bodies in a microtubule- dependent manner to the sites of translation. VSV
mRNAs do not contain cis-acting sequences that influence translation but they do contain
cis-acting sequence-independent structural elements, which enhance translation efficiency
50
of the viral mRNAs. These structural elements may be utilized by cellular large ribosomal
subunit protein rpL40 to facilitate formation of 80S ribosome on VSV mRNAs for
53
translation. rpL40 is required for cap-dependent translation of VSV, measles, and rabies
virus mRNAs but not for cellular cap-dependent or internal ribosome entry site-driven
mRNA translation. Thus, rpL40 is a host ribosomal protein that facilitates translation of
mRNAs of several members of Mononegavirales, including VSV.
Another mechanism by which VSV mRNAs are preferentially translated is by global
shutdown of host transcription and translation through the viral M protein. The M protein
interacts with the nuclear export pathway proteins Rae1 and Nup98 and thereby blocks
the export of nascent cellular transcripts from the nucleus to the cytoplasm, resulting
54,55
in shutoff of host protein synthesis.
Recent studies support a model in which the
VSV M-Rae1 complexes allow interaction of the M protein with factors involved in
56
transcription, resulting in inhibition of cellular transcription. During VSV infection,
inactivation of the basal transcription initiation factor TFIID leading to downregulation of
57
the host RNA polymerase II activity has been observed, although detailed mechanisms
are yet to be uncovered. The possibility that the M protein dismantles TFIID by targeting
the phosphorylation or the function of TATA-binding protein of TFIID complex has been
58
implicated.
Viral Genome Replication
VSV genome replication is carried out by the viral replicase complex, which is primarily
composed of the P and L proteins. Recent studies have identified various host factors
59
that positively influence viral genome replication. The chaperone protein HSP90AB1
was found to enhance the stability of VSV RdRp polymerase while cytoskeleton protein
60
tubulin may associate with VSV L protein thereby facilitating viral genome replication.
Studies have also implicated a role for the cellular La protein in VSV RNA replication.
The La protein, which is normally associated with the pol III transcripts, was also shown
to be specifically associated with the plus-strand and longest minus-strand (54 nt) leader
61,62
RNAs in VSV-infected cells.
The association correlated with enhancement in genome
replication but the exact role of La protein, if any, remains to be deciphered.
Host Functions in VSV Assembly and Budding
VSV assembly occurs at the plasma membrane and is mediated by the viral M and G
proteins. Current evidences indicate that VSV RNA and the individual proteins are
transported to the plasma membrane via different routes. The G protein is synthesized in
association with the ER where it is glycosylated and transported to the Golgi apparatus for
processing of the glycan moieties and is finally transported to the plasma membrane. The
63
cellular secretory pathway is used for transport of G protein to the plasma membrane,
64
where it forms membrane microdomains important for VSV budding. In addition to the
65
role played by coatomer protein complex II (COPII) and COPI in VSV G protein transport
(see section 5.1 below), the maturation and transport of VSV G protein also requires the
66
presence of the trafficking protein particle complex subunit 3 (Bet3), which functions
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downstream of COPII and upstream of Rab1, alpha-SNAP and the EGTA-sensitive stage
during the ER-Golgi transport. The vesicle-trafficking protein SEC22b, which functions at
67
the level of the intermediate compartment (IC) in ER- Golgi transport, is also required.
VSV M is a soluble protein and is brought to the plasma membrane by an unknown
mechanism, but the association of M protein with the plasma membrane results in
68
formation of microdomains, which is independent of the G protein. The viral NC, with
the associated polymerase complex is assembled in the cytoplasm and is then transported
51
to the plasma membrane in a microtubule dependent manner where it associates with M
69
protein.
After assembly, virus budding and release continue to depend on the function of the
M protein and its cellular interacting partners. The N terminal region, especially the
amino acid 17-33 of M protein contains a PPxY motif that interacts with WW (tryptophan)
domains of cellular proteins such as Yes-kinase associated protein (YAP) to recruit them to
70,71
the site of virus budding.
Additionally, the interaction between M protein and dynamin
72
1 and 2 also promotes viral assembly and budding. Since enveloped virus budding and
73,74
release is considered to be topologically equivalent to MVB biogenesis,
several of the
factors including the ESCRT machinery are also required for VSV budding and release.
Although the tumor susceptibility gene 101 protein (TSG101), a member of the ESCRT-I
75
machinery appears to be dispensable for VSV budding, the role of vacuolar protein
sorting-associated protein 4A (VPS4A), an AAA+ ATPase required for disassembly and
76
recycling of ESCRT components, remains somewhat unresolved. In one study, the use of
75
dominant negative VPS4A mutant showed that VPS4A is not essential for VSV budding;
however in a separate study, dominant negative forms of both VPS4A and 4B were shown
77
to inhibit VSV budding. Nevertheless, the ESCRT machinery is required for scission of
the viral membrane from the plasma membrane during budding (see chapter 8 for further
details). In addition, the proteasomal pathway has been found to be indispensable for the
77-79
virus budding.
The lipid composition of the membrane bilayer and lipid biogenesis
may also play certain roles in the binding of M protein to the host cell membrane, since it
80
was shown that triacylglycerol synthesis might interfere with virus maturation. A recent
mass-spec analysis of virion-associated proteins revealed a number of cellular proteins
including integrin β1, HSP90, HSP cognate 71, annexin 2, EEF1A1 to have been packaged
81
in the VSV virions. These cellular proteins may potentially be involved in virus assembly,
budding, and/or in other stages of virus infection processes. Functional studies of these
proteins will be required to understand and appreciate their role in VSV life cycle.
Cellular Pathways that Regulate VSV Infection
In the previous sections, we described the role(s) of many individual host factors that
facilitate or restrict VSV replication at various stages. Many of these factors appear to be
involved in multiple steps of the viral life cycle. Cross-talk between various host factors
and the pathways they represent also seems to be important for efficient multiplication or
efficient restriction of replication of the virus. In several chapters of this book, the role(s) of
many of these pathways in VSV infection have been described and the reader is directed to
those chapters for further details. Although the list of factors and pathways that regulate
VSV infection is by no means complete and will likely grow in the future, we describe below
several of the major pathways and the associated factors that influence VSV replication.
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Endocytic and Secretory Pathways
As described above (section 2.2), factors associated in CME are required for entry of VSV.
The host proteins in the endocytic pathway and their roles in viral entry and nucleocapsid
uncoating have been described in greater detail in chapter 3.
The secretory pathway plays a critical role in VSV replication cycle. This pathway
involves anterograde and retrograde transport of proteins and lipids, which are mediated
by vesicles containing distinct sets of cytosolic coat protein complexes, the (COPII) and
82,83
(COPI), respectively.
Early studies revealed that the transport of VSV G from its site of
synthesis in the ER to the Golgi and finally to the plasma membrane requires both COPII
65
and COPI. In these studies, the newly synthesized G protein was found to accumulate in
COPII-containing vesicles at the ER, which then fuse to form larger transport complexes or
ICs. In these ICs, the COPII is then replaced by COPI and the vesicles are then transported
to the Golgi complex in a microtubule-dependent manner, thus suggesting a sequential
65
mode of action of these two coatomer protein complexes in VSV G protein transport.
In addition to its role in G protein transport, the secretory pathway and, in particular, the
84
COPI, also appears to play an important role in VSV gene expression. The observations
that (i)VSV gene expression is inhibited in COPI-depleted cells that are independent of
the viral G protein processing and transport, (ii) pharmacologic inhibitors of COPI inhibit
VSV gene expression as well as reduce viral RNA levels, (iii) viral gene expression requires
the ADP ribosylation factor 1 (ARF1) and the Golgi-associated brefeldin A resistant factor
1 (GBF1), the two upstream effectors of COPI function, and (iv) VSV gene expression is
reduced in nucleocapsid transfected cells that have been depleted of COPI strongly suggest
84
a role for COPI function in viral RNA synthesis. Additional evidence for the involvement
of COPI in VSV RNA synthesis comes from studies using cells having a temperature85
sensitive _-COP, a subunit of the heptameric COPI complex. Mechanistically, whether the
COPI complex is directly involved in regulating the viral polymerase functions or whether
it may signal through downstream effectors essential for viral gene expression is not known
51,52
at this time. VSV replicates throughout the cytoplasm of infected cells,
although the
existence of specific replication organelles in the cytoplasm whose assembly requires COPI
function cannot be ruled out. The requirement of COPI for genome replication has been
well documented for positive- strand RNA viruses, which replicate in association with
86
cytoplasmic membranous structures. Further biochemical and ultrastructural studies in
cells infected with VSV will likely illuminate the nature of the replication organelles, if any,
for these viruses.
Innate Immune Signaling Pathways
Host cells survey invasive RNA viruses including VSV by the viral ssRNA, dsRNA
or glycoproteins using either membrane-associated or cytosolic pattern recognition
receptors (PRRs) to mount a well- orchestrated innate immune defense (see chapter 15
for further details). The membranous PRRs like toll-like receptor 4 (TLR4) present at the
plasma membrane as well as TLR3, TLR7 and TLR8 in the endosomes, recognize the
VSV glycoprotein (VSV-G) or RNA and transduce downstream antiviral signaling that
culminates in the activation of transcription factors such as IFN regulatory factors 3 (IRF3),
87,88
IRF7, IRF5 and/or nuclear factor κB (NF-κB),
leading to the production of IFN and
proinflammatory cytokines by the infected cells. Recently, TLR13, a novel member of the
mammalian TLR family was reported to activate type I IFN production via activation of NF89
κB and IRF7. TLR13 seems to detect VSV at the surface of dendritic cells, macrophages or
cells of the spleen where it is predominantly expressed. VSV RNP contributes to the early
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recognition of infection by the cytoplasmic PRRs consisting of the retinoic-acid-inducible
gene I (RIG-I) and the melanoma differentiation-associated protein 5 (MDA5). RIG-I plays
a major role in sensing VSV infection, since type I IFN production was found to be severely
-/impaired in VSV infected RIG-I MEFs compared to wild-type cells whereas MDA5 was
90
dispensable.
PRR signaling results in production and secretion of IFN-α/β, which in autocrine
or paracrine fashion, activate the JAK-STAT signaling pathway leading to synthesis of
hundreds of interferon stimulated gene (ISG) products. Many ISGs, such as, phospholipase
91
92
93
C (PLC) and phospholipase A2 (PLA2), guanylate binding protein-1 (GBP-1), and Mx1
are well-known for their antiviral effects against VSV, but the mechanism(s) of their action
is poorly understood. A recent functional ISG screen documented 34 ISGs showing antiviral
activity against VSV; included among them are novel ISGs such as ISG20, IFITM3, OAS1,
94
MGA T1, GPR146, P ARP12, L Y6E, APOBEC proteins. ISGs antagonize various stages of the
VSV life cycle. The enzyme, cholesterol-25-hydroxylase, generates 25-hydroxycholesterol
(25HC) which then suppresses VSV and several other enveloped virus infections by
95
blocking the membrane fusion step. IFITM3 disrupts an early event after endocytosis
96
but before primary transcription, whereas the viral primary transcription step is blocked
97
by poly (C) binding proteins 2 (PCBP2). Viral genome transcription and replication are
efficiently blocked by 2',5'-oligoadenylate (2-5As) and 2-5As synthetases (OASs). One of
the well-characterized inhibitors of VSV translation is the double- stranded RNA-activated
98
protein kinase (PKR). PKR modulates the inhibitory effect through multiple mechanisms,
the most prominent being the phosphorylation of the eukaryotic translation initiation factor
99
2α (eIF2α) and subsequent shutoff of host and viral translation. The other mechanism
involves phosphorylation of nuclear factor associated with dsRNA 1 and 2 (NFAR1/2)
protein, which is then retained on the ribosomes, associates with viral transcripts and
100
thereby sequesters viral mRNA from being translated. Other ISGs suppress VSV growth
at translation and replication steps. The promyelocytic leukemia (PML) protein interferes
with VSV mRNA synthesis, protein synthesis, and contribute to the antiviral state induced
101, 102
103
in mice infected with VSV.
This antiviral effect requires PML SUMOylation. The
final step in the VSV life cycle, virus budding, is inhibited by tetherin, which blocks virion
96
particle release from infected cells.
Contrary to the classical function of ISGs as antiviral effectors, many ISGs also
play a negative regulatory role to prevent excessive IFN production. A number of ISGs
such as ISG56 and gC1qR negatively regulate the VSV antiviral response by interfering
104,105
with interactions of the STING/MITA, IPS-1/VISA, and TBK1,
whereas other ISGs
106,107
such as TRIAD3a, TRAF induce degradation of TRAF3 and TBK1, respectively.
Recently, studies from our laboratory identified the interferon inducible protein IFI35 as a
108
negative regulator of RIG-I antiviral responses during VSV infection. IFI35 was found
to interact with RIG-I and the RIG-I activity was attenuated through maintenance of its
inactive, phosphorylated form and also through degradation of RIG-I by K-48-linked
108
ubiquitination. It appears that an intricate balance between the activities of various ISGs
during VSV infection may modulate the outcome of the infection, although additional
factors may also be involved.
In recent years, autophagy has emerged as an important pathway complementing
the innate immune pathways. Autophagy is an evolutionarily conserved mechanism
in eukaryotes for degradation of unwanted intracellular cargo. Studies have shown
autophagy to play an antiviral or proviral role depending on the virus and the host cell
109
110
type. For VSV, autophagy plays an antiviral role in the Drosophila model. Recent
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studies have demonstrated that VSV infection induces autophagy in Drosophila cells via
TLR-7-mediated recognition of VSV G protein from replication-competent VSV , UV
inactivated (replication- incompetent) VSV or VSV-G harboring virus like particles (VLPs),
suggesting the VSV G protein as the pathogen associated molecular pattern (PAMP) that
stimulates the autophagy pathway. Interestingly, the AKT-mTOR axis involved in nutrient
111
signaling also plays a role in activating the antiviral autophagy program. In contrast,
many positive sense RNA viruses like Dengue, Hepatitis C virus (HCV) and some DNA
viruses like Kaposi sarcoma herpesvirus (KSHV) have been found to utilize autophagy
as a proviral mechanism, which makes this pathway a necessary evil for the host in these
109
cases.
Apoptotic and Cell Survival Pathways
112
VSV infection initiates both intrinsic (mitochondrial) apoptosis through caspase-9 and
113
extrinsic apoptosis through PKR, DAXX, and partly via Fas and caspase-8 (see chapter
7 for further details). Apoptosis can occur at an early stage of VSV life cycle without a
114
requirement for RNA replication. The apoptotic consequence is thought to be primarily
115,116
due to viral M protein and leader RNA
in addition to the alteration of levels of proteins
117,118
in apoptotic pathways.
The molecular mechanism for IFN to regulate VSV induced
119,120
apoptosis is not clear yet but several signaling factors including STAT,
the ISGs such
121,122
123
as PKR and OAS
and the apoptosis-inducing factor p53 appear to be involved.
In addition, cross-talk between apoptosis and innate immune response in VSV infection
is responsible for induction of the intrinsic apoptotic pathway involving Bax-Caspase-9,
124
which triggers phosphorylation of IRF3 and downstream type I IFN production.
Initiation of apoptosis by VSV M protein requires cellular factors and is cell-type
dependent. Wt VSV induces faster apoptosis in HeLa cells than the mutant VSVM51R
125
virus but it is the reverse in BHK-21 cells. Consistent with this observation, we recently
demonstrated a role for hnRNP K in supporting VSV infection through suppressing
117
apoptosis induction and promoting survival of infected cells. The studies revealed that
hnRNP K helps maintain the low levels of expression of proapoptotic proteins such as
BiK and Bcl-XS and high levels of expression of antiapoptotic proteins such as Bcl-XL,
117
Bag1, and Bcl-2. Additionally, hnRNP K supports expression of several cellular factors
required for VSV replication and negatively regulates expression of cellular factors known
to inhibit VSV replication. In particular, hnRNP K suppresses overall levels of total T-cell
intracellular antigen 1 (TIA1) as well as expression of the TIA1b isoform (a differentially
117,126
spliced form of TIA1a); both isoforms of TIA1 suppress VSV replication.
Studies of
the hnRNP K interactome revealed more than 100 interacting partners and determined
that hnRNP K protein is present in the nucleus, cytoplasm, mitochondria, and the vicinity
127
of the plasma membrane. Thus, it is possible that hnRNP K exerts its positive impact on
VSV growth through one or more of its interacting partners and may be involved in crosstalk between multiple pathways required for efficient VSV replication. The requirement of
hnRNP K in VSV replication and the observation that hnRNP K levels in many cancerous
cell types is upregulated may add to the understanding of why tumor cells provide an
appropriate microenvironment (in addition to defective type I IFN response and signaling)
for efficient VSV growth.
In contrast to the function of hnRNP K, hnRNPA1 plays a supporting role in VSV
128
mediated apoptosis. Studies have shown that VSV infection leads to a decrease of other
129
antiapoptotic proteins such as keratinocyte transcription factor TP63 and myeloid cell
130
leukemia 1 protein (Mcl-1), while proapoptotic Bax was increased in the immortalized
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129

HaCaT keratinocyte cell line. miR-706 is upregulated in VSV infection and is able to
inhibit VSV-induced apoptosis by decreasing caspase-3 and -9 activation, suggesting that
induction of miR- 706 expression may be a novel strategy for survival of VSV, allowing it
131
to escape the apoptosis response of the host.
Akt/phosphatidylinositol-3-kinase (PI3K) pathway is a major cellular pathway
controlling cell growth, proliferation, translation, and suppression of apoptosis. A variety
of viruses are known to modulate this pathway. The observations that treatment of cells
132
with Akt inhibitors significantly reduced VSV growth and constitutively active Akt
133
enhanced VSV replication suggest that the Akt pathway is important in VSV replication.
However, conflicting data also exist as to the role of this pathway in viral replication. Akt
is activated in macrophages infected with VSV and this leads to the inhibition of virus
134
135
replication. Similarly, inactivation of Akt also favors VSV replication in BHK-21 cells.
110
On the other hand, downregulation of Akt in Drosophila suppresses VSV replication.
RNA Interference (RNAi) Pathway
The cellular RNA interference (RNAi) pathway, which is an innate immune defense
mechanism to control viral infections in plants and insects, is also involved in regulating
136,137
VSV infection. This was first demonstrated in the worm Caenorhabditis elegans.
Cells
derived from mutant worms defective in the RNAi response supported higher levels of
VSV replication as compared to the cells from the wild-type counterpart indicating that the
136,137
RNAi pathway controls replication of VSV.
In Drosophila, RNAi-mediated response
138,139
also confers protection against infection by VSV.
Depletion of the arsenite resistance
protein 2 (Ars2), which is required for siRNA- and miRNA- mediated silencing, results
139
in increased replication of VSV in Drosophila cell cultures and adult flies. The RNAi
140
pathway has been shown to be inducible by IFN and thus constitutes another arm of
141
142
the innate host defense against a variety of virus infections in vitro and in vivo. Mice
hypomorphic for Dicer, the endoribonuclease that catalyzes production of siRNAs and
miRNAs, are more sensitive to VSV infection due to impairment in production of miR24
143
and miR93, highlighting an important role for miRNAs in antiviral defense against VSV
in mammalian systems. The miR93 and miR24 target the viral mRNAs for the P and L
proteins, respectively, and thus suppress VSV replication. The cellular RNAi pathway also
participates in controlling the appropriate response of innate immunity to VSV infection.
Some miRNAs such as miR-146a and miR-466l negatively regulate type I IFN responses and
144,145
support VSV infection.
Thus, the important role of the RNAi pathway in regulating
VSV replication is being increasingly appreciated.
ESCRT Pathway
The ESCRT pathway is intimately involved in steps during virus entry as well in virus
assembly and exit from the cells. The specific role(s) of various ESCRT subunits in the VSV
life cycle has been detailed in chapters 3 and 8.
Stress Response Pathway
The crosstalk between stress induced responses and cellular innate immunity has been
established in cellular responses to suppress VSV infection. It is known that VSV infection
146
induces both oxidative stress and an anti-oxidative response in mammalian cells.
Stressful conditions such as viral infections, hypoxia, heat shock, UV irradiation, amino
acid starvation or oxidative stresses induced by arsenite treatment can activate one or more
of the five putative eIF2α kinases (PERK, GCN2, PKR, HRI and Z-DNA kinases). eIF2α
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phosphorylation results in global shutoff of cap-dependent translation with the exception
147,148
of proteins belonging to the stress response pathway, such as heat shock proteins.
Stress-induced Growth Arrest and DNA Damage- inducible protein 34 (GADD34) is
133
induced by VSV infection. It suppresses viral replication by inhibiting the mTOR
133
pathway, which is required for viral protein synthesis. These studies indicate that the
stress- inducible response plays a critical role in antiviral defense against VSV. In addition,
hypoxia-inducible factor (HIF) plays an antiviral role in VSV infection by upregulating
149
type I IFN and ISGs production.
A functional proteasome pathway also seems to be important for VSV protein
synthesis since proteasome inhibitors significantly suppress viral protein synthesis
150
through stimulation of stress-related responses such as phosphorylation of eIF2α. The
host protein, REgulated in Development and DNA Damage responses 1 (REDD1), which
151
is usually induced in cells undergoing ER stress, is initially induced at early stages
of VSV infection but quickly decreases back to normal levels at 4 hpi due to the global
152
suppression of translation by VSV M protein. The demonstration of antiviral activity by
the small molecules, nephthalimides, through upregulation of REDD1 and concomitant
inhihition of mTORC1 suggest that mTORC1 plays an important role in regulation of VSV
replication. The requirement for activation of mTORC1 for VSV infection appears to be
152
for viral mRNA translation. In addition to its role in translational control, mTORC1 is
known to stimulate type I IFN production through phosphorylation of p70S6K and 4E153,154
BP1.
These findings suggest that exploitation of mTORC1 pathway may be another
mechanism that VSV employs to facilitate viral mRNAs translation. However, the
apparent paradoxical effects of mTORC1 activation on stimulation of IFN production and
upregulation of VSV replication needs further investigation to help clarify and determine
the mechanistic involvement of mTORC1 in VSV replication.
Other Factors and Pathways
Post-translational modifications such as glycosylation, phosphorylation, ubiquitination,
SUMOylation, ISGylation, etc, affect the maturation of viral proteins and thus regulate VSV
replication. These modifications also influence activities of many host cell proteins that
regulate VSV infection. Prostaglandin A1 (PGA1) and the delta12-Prostaglandin J2 (delta
12-PGJ2), a naturally occurring dehydration product of prostaglandin D2, inhibit VSV
155,156
growth via suppression of synthesis and post-translational glycosylation of G protein.
The activity of VSV P and M proteins are also affected by type I IFN in neuronal cells,
whereP is hypophosphorylated and M is hyperphosphorylated. Hypophosphorylated P
40-43
may affect VSV replication and transcription
whereas hyperphosphorylated VSV M
157
protein inhibits its association with VSV nucleocapsid. These studies suggest a possible
mechanism for type I IFN-mediated misassembly through disruption of the interactions
157
between viral RNP and the M protein. The VSV M is ubiquitinated by Rsp5 ubiquitin
78
ligase and thus may play a role in virus assembly and budding.
The hnRNPU, a protein involved in pre-mRNA processing, specifically interacts
with the VSV leader RNA in the nuclei and colocalizes with the viral RNP in the cytoplasm.
158
hnRNPU is also packaged within purified VSV virions but its role in the viral life cycle
remains to be examined. In contrast, PCBP1 and PCBP2, cellular regulators of splicing,
transcription, translation, and mRNA stability, interact with VSV P and function as negative
97
regulators of virus gene expression. Further studies reveal that TIA1, a PCBP2-interacting
147,159
partner and a critical factor for stress granule formation,
also functions as a negative
126
regulator of VSV gene expression.
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The PI3K/Akt/NF-κB pathway requires the presence of Grb2- associated binder
1 (Gab1), a member of scaffolding/adaptor proteins, to protect macrophages from VSV
160
infection. Akt1 phosphorylates and inactivates the transcription repressor EMSY,
resulting in its inability to bind to ISG promoters, leading to the expression of ISGs and
161
inhibition of VSV growth. The protein arginine N-methyltransferase (PRMT1) specifically
binds to the intracytoplasmic domain of the type I IFN receptor to transduce the antiviral
162
signaling mediated by IFN-β. The involvement of PKC in the antiviral response to
163
VSV infection mediated by hormone oxytoxin in human amnion cells and by cAMP in
164
macrophages has been noted. On the other hand, the tyrosine receptor kinase (TRK)fused gene (TFG) protein plays a supportive role in VSV infection by negatively regulating
165
the RIG-I/MAVS/NF-κB axis of antiviral signaling.
Other factors, such as, HSP70 facilitates type I IFN-dependent antiviral immunity
166
against VSV in neurons, whereas Cancer Upregulated Gene 2 (CUG2), a novel oncogene,
167
makes cells resistant to VSV through the activation of STAT1-ISGs signaling. In addition
to type I IFN, type II and type III IFNs antagonize VSV infection and replication. Type
168
III IFNs (IFN-λ1, -λ2, and -λ3) are induced during VSV infection and mediate antiviral
responses similar to type I IFN. IFN-λ1 is more effective than the other two members.
169,170
IFN-γ inhibits VSV infection
through inhibition of VSV protein synthesis as a result
171
of upregulation of NOS-1 and increased NO production in neuronal cells. In cells of the
reticuloendothelial system, IFN-γ treatment induces the expression of a set of low molecular
weight MHC- encoded proteins (LMPs), which replace the beta-subunit of the proteasome
complex during the proteasome neosynthesis, resulting in an antiviral complex termed the
171
immunoproteasome in neuronal cells that restricts VSV replication.
Concluding Remarks and Future Perspectives
VSV requires many cellular factors and pathways for efficient replication in host cells.
Likewise, the host cells respond to VSV infection by expressing and/or activating factors
and pathways to restrict virus replication. It is the net effect of these opposing factors/
pathways that likely determines the outcome of the virus infection. As discussed above,
mechanistic understanding of many factors that regulate VSV infection has been achieved;
however, our current understanding of the role(s) of many others remains elusive. At this
84,172
29
time, two genome-wide siRNA screens,
a kinome screen for the endocytic pathway
152,173
and at least two antiviral small molecule screens
have revealed many interesting
cellular factors that regulate VSV infection at multiple stages in the viral life cycle (Fig.
1). Understanding of the role(s) of these proteins and cross-talk between them and the
cellular pathways involved in the VSV life cycle is of paramount significance for a better
understanding of VSV-host cell interactions. VSV is not only used as a model pathogen
for understanding the mechanisms of replication and pathogenesis of this class of viruses,
it is also used as a vaccine vector and an oncotherapeutic agent. Therefore, a complete
understanding of VSV-host interactions will also be crucial for development of more
efficacious vaccine vectors and oncolytic VSV.
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